CG MedTech Co

CG MedTech Co Net Debt per Share

The Net Debt per Share of CG MedTech Co (056090.KQ) as of Oct 20, 2026 is 9.16 KRW. In the previous year, Net Debt per Share was 15.43 KRW — a change of -40.63% (lower).

Net Debt per Share

9.16KRW

YoY

-40.63%

Last updated:

Net Debt per Share of CG MedTech Co is 2025 9.16 KRW. Net Debt per Share of CG MedTech Co was 2024 15.43 KRW. It decreases by -40.63% lower compared to the previous year.

The CG MedTech Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2017
-95.89 KRW
Jan 1, 2018
131.29 KRW
Jan 1, 2019
186.22 KRW
Jan 1, 2020
149.44 KRW
Jan 1, 2021
104.31 KRW
Jan 1, 2022
703.42 KRW
Jan 1, 2024
15.43 KRW
Jan 1, 2025
9.16 KRW
The CG MedTech Co Net Debt per Share history
YEARNet Debt per ShareYoY
9.16KRW-40.63%
15.43KRW-97.81%
703.42KRW+574.37%
104.31KRW-30.20%
149.44KRW-19.75%
186.22KRW+41.84%
131.29KRW-236.92%
-95.89KRW-63.40%
-261.98KRW-360.26%
100.66KRW-33.21%
150.70KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Net Debt per Share of CG MedTech Co is 9.16 KRW in 2025.

Net Debt per Share of CG MedTech Co changed from 15.43 KRW to 9.16 KRW, representing a -40.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — CG MedTech Co

All Key Metrics — CG MedTech Co